Lv1
80 积分 2025-11-04 加入
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
1小时前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
已完结
756-P: A Phase 1c Evaluation of a Novel GLP-1 Analog Ecnoglutide (XW003) for Weight Loss in Adults with Overweight and Obesity
2小时前
已关闭
Quantitative In Silico Analysis of D-Amino Acid Oxidase Reactivity and Inhibition
4个月前
已关闭
Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis
5个月前
已完结
Flexible nanoelectronics reveal arrhythmogenesis in transplanted human cardiomyocytes
5个月前
已完结
Cardiac delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs) for treating genetic cardiomyopathies
6个月前
已关闭
Aptamer-Drug Conjugates (ApDCs): Transformative approaches in targeted cancer therapy and precision oncology
11个月前
已完结
皖公网安备34019202002308
